Supplementary Figure 1 from Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-α Results in the Activation of Specific CD8<sup>+</sup> T Cells and Monocyte/Dendritic Cell Precursors

Tiziana Di Pucchio,Lorenzo Pilla,Imerio Capone,Maria Ferrantini,Enrica Montefiore,Francesca Urbani,Roberto Patuzzo,Elisabetta Pennacchioli,Mario Santinami,Agata Cova,Gloria Sovena,Flavio Arienti,Claudia Lombardo, Arianna Lombardi, Patrizia Caporaso, Stefania D'Atri,Paolo Marchetti,Enzo Bonmassar,Giorgio Parmiani,Filippo Belardelli,Licia Rivoltini

crossref（2023）

引用 0|浏览4

暂无评分

摘要

Supplementary Figure 1 from Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-α Results in the Activation of Specific CD8⁺ T Cells and Monocyte/Dendritic Cell Precursors

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Figure 1 from Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-α Results in the Activation of Specific CD8&lt;sup&gt;+&lt;/sup&gt; T Cells and Monocyte/Dendritic Cell Precursors

Supplementary Figure 1 from Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-α Results in the Activation of Specific CD8<sup>+</sup> T Cells and Monocyte/Dendritic Cell Precursors